MedPath

Back pain management by ayurvedic procedure

Phase 2
Completed
Conditions
Other spondylosis,
Registration Number
CTRI/2020/02/023356
Lead Sponsor
IPGT and RA GAU Jamnagar
Brief Summary

The trial initiated with the aim and objective to assess the clinical efficacy of *Agnikarma* and *Raktamokshana*in the management of *Kati Sandhigata Vata* (Lumber spondylosis). In this study total of 32 patients were enrolled which were allocated into two non-comparative clinical parallel groups. 15 patients in Group A and 15 patients in Group B completed treatment as well follow-up, 2 patients were dropped out during treatment time.

In Group A 15 patients were managed with *Agnikarma* by *Panchdhatu Shalaka* at the most tender area in the lumbar region. 4 sittings were done with an interval of 7 days for the period of one month.

In Group B 15 patients were managed with *Raktamokshana* by modified *Shringayantra* (Chinese Cups) in the most tender in the lumbar region. 2 sittings were performed with an interval of 15 days.

The assessment was done on relief in sign and symptoms of *Kati Sandhigata Vata* like *Kati Shoola* (Lumber pain), *Kati Stambha* (Lumber stiffness), *Kati Suptata* (Lumber numbness), *Akunchana Prasarane Pravritti Savedana* (restricted lumber joint movements) weekly for 1 month. Follow-up was done up to 1 month for the period of one month after the treatment in both groups.

The study concluded that both the para-surgical modalities are highly effective in managing chiefcomplaints like *Agnikarma* is better in managing *Kati Shoola* (Lumberpain) and *Kati Stambha* (Lumber stiffness) while *Raktamokshana* isbetter in managing *Kati Suptata* (Lumber Numbness) and *AkunchanaPrasarane Pravritti Savedana* (Restricted lumber joint movement) but statically there is an insignificant difference among them i.e., the null hypothesis is accepted and the alternate hypothesis is rejected for this trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

Patient suffering from kati Sandhigata Vata (Lumber Spondylosis) irrespective to demographic data Patients between age group 30-70 years of both sex Yogya of Agnikarma Twak Mansh Sira Snayu Sandhi Asthi Sthit Vayu Pidit Vayu ucchit Kathin Suptmansh Granthi Arbud Arsh Bhandar Apachi Shlipad Charmkeel Tilkalaka Antravridhi Sandhi Sira Chhedan Nadishonit Atiprivriti Yogya of Raktmokshan Mukhpaka Akshiroga Pootigranaasytagandhita Gulm Upkush Visharpa Raktpitt Pramilika Vidhradi Raktameh Pradar Vatashonit Vivaranya Agnisaad Pipasagurugatrta Santap Atidorbalya Aruchi Shirsch Ruk.

Exclusion Criteria
  • Patients of uncontrolled diabetes mellitus R.A. (Rheumatoid arthritis) positive.
  • Other diseases like paralysis Parkinson’s disease severe anaemia malignancy Patients below 30 years and above 70 years Pregnancy Protrusion of lumbar disc & disc prolapse Heart disease(IHD,CCF) Ayogya for Agnikaram Pitta dominant Prakruti patients Antashonit (Internal Haemorrhage) Bhinnkostha (Diarrhoea) Anudhrit shalya (Unexpelled foreign object ) Durbal(Weak) Bala(Minors) and Vridh (old age) Bhirum (Scared) Anek Vran Pidit(multiple wound affected) Asvedhya(Swedan Aayogya) Ayogya for Raktmokshna Sarvangsoph (Ana sarca) Kshin chha Amalbhojananimit(weak person with Sour diet intake) Pandu rogi (anaemic) Arsh rogi (Piles in Ano) Udar rogi (Abdominal disease) Shosh rogi (Koch’s disease) Garbhini (Pregnant women).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in sign and symptoms of kati Sandhigata Vataone month from the day of enrollment of patient
Secondary Outcome Measures
NameTimeMethod
Improves quality of life of personAfter 2 months from the day of enrollment

Trial Locations

Locations (1)

PG Hospital IPGT AND RA JAMNAGAR

🇮🇳

Jamnagar, GUJARAT, India

PG Hospital IPGT AND RA JAMNAGAR
🇮🇳Jamnagar, GUJARAT, India
Poona nath chouhan
Principal investigator
7742038214
www.poonanath@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.